Bullish vs. Bearish (2 opinions)
Social Sentiment 0.25
BIOC Forecast and Technical Stock Analysis
Sell candidate since 2019-08-13 Loss -11.78%
Biocept gained 0.53% in the last trading day ( Friday, 16th Aug 2019 ), rising from $0.91 to $0.92 During the day the stock fluctuated 8.26% from a day low at $0.88 to a day high of $0.95. The price has fallen in 5 of the last 10 days and is down by -11.78% for this period. Volume fell in the last day by -616 668 shares and in total, 405 490 shares bought and sold for approximately $372 037.00. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
- 30 day high of the BIOC stock price was $1.15 and low was $0.88.
- 90 day high was $2.11 and low was $0.88.
- 52 week high for Biocept - $3.88 and low - $0.66.
Biocept lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.14% during the next 3 months and, with 90% probability hold a price between $0.66 and $1.16 at the end of this period.
A buy signal was issued from a pivot bottom point on Thursday August 15, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Biocept holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $1.00 and $1.03. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Relative Strength Index (RSI)
RSImin/max Values: [ 20 - 75 ]
RSI14 is 36 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Biocept finds support from accumulated volume at $0.91.
In general the stock tends to have controlled movements, but the low liquidity has increased the risk substantially.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
7.22 %Average volatility
Very Low Low Medium High Very High
Biocept holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.
|BIOC $0.92 ($0.00 0.53%)|
BIOC is up $0.00 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for BIOC based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the BIOC analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!